NEW YORK ( TheStreet) -- "Mad Money" Research Director Nicole Urken met with TheStreet's Jim Cramer to discuss some powerful cancer-fighting procedures that have begun to emerge.With the American Society of Clinical Oncology conference wrapping up this week in Chicago, some old-name pharmaceutical stocks are getting a boost for their recent progress on cancer-fighting techniques.
Cramer Quick Take: Focus on ASCO
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.